Timeliness and actionable intelligence over I-Banks research which remains only geared to institutional investors and legacy processes. News carries with it a promise of transparency, a light that can be shined into previously dark corners.
But they don’t define any relevance to the actual value of a release - mostly due to SEC forward looking parameters. However, this news portal has been expanded to … supplement, measure and price the event and relevance to a company’s ... valuation.
September 11, 2019
Remember and never forget!
August 8, 2019
Stemline Therapeutics (STML) proposes 5 M share offering
August 5, 2019
Regenerative Medicine Earnings Scorecard - Q2/19 - to date
April 8, 2019
Histogenics (HSGX) reverse mergers with Ocugen, Inc.
February 26, 2019
Sage Therapeutics (SAGE) prices 3.33 M share offering at $150.00
January 29, 2019
RegMed Investors’ (RMi) mid-day: bottoms bounce
January 21, 2019
RegMed Investors’ (RMi): worried about 2019, investors better be!
January 15, 2019
Alnylam Pharmaceuticals (ALNY) priced 5 M share offering at $77.50
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at firstname.lastname@example.org.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors